Prevention of motion sickness with selegilinum hydrochloricum.
Summarizing, it may be concluded that selegilinum hydrochloricum significantly prolongs the time before the development of nausea and vomiting provoked by vestibular stimulation. The drug controls, within a short period, the provoked discomfort, and restores normal condition rapidly. It prevents the changes in blood pressure, pulse rate, and cutaneous galvanic resistance following Coriolis stimulus. Due to these properties Jumex may be used for the prevention, moderation of motion sickness, one of the widespread phenomena of our age, without decreasing working capacity.
Bodó
G
G
Elkán
K
K
Bencze
G
G
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation; D006801:Humans; D008297:Male; D009041:Motion Sickness / Q000188:drug therapy* / Q000517:prevention & control; D010627:Phenethylamines / Q000494:pharmacology*; D012642:Selegiline / Q000008:administration & dosage / Q000494:pharmacology*
D010627:Phenethylamines; D012642:Selegiline